Navigation Links
ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results
Date:10/30/2007

a higher clinical success rate than patients on metronidazole or the investigational compound. These data confirm the efficacy and safety of Vancocin in patients with severe CDAD and we expect that these data and the IDSA/SHEA guidelines for treatment of CDAD will be strongly considered in treatment recommendations."

Net income in the third quarter and nine-months ended September 30, 2007 was $21.3 million and $75.0 million, respectively, compared to a net income of $23.3 million and $48.7 million for the same periods in 2006. Net income per share for the quarter ended September 30, 2007 was $0.30 per share, basic and $0.26 per share, diluted, compared to a net income of $0.34 per share, basic, and $0.33 per share, diluted, for the same period in 2006. Net income per share for the nine-months ended September 30, 2007 was $1.07 per share, basic, and $0.96 per share, diluted, compared to a net income of $0.71 per share, basic, and $0.69 per share, diluted, for the same period in 2006.

The primary drivers of the change in net income for the third quarter were the effects of decreased operating income discussed above, offset by increased interest income and a lower effective tax rate. Net income for the nine month period increased primarily due to higher net sales.

Operating Highlights

During the three and nine months ended September 30, 2007, net sales of Vancocin decreased 7.6 percent and increased 21.8 percent, respectively, compared to the same periods in 2006. The decrease in net sales of 7.6 percent resulted from fewer units sold to wholesalers in the third quarter of 2007 than during the third quarter of 2006 as a result of wholesaler buyer decisions to increase inventory levels in the third quarter of 2006. The nine month increase of 21.8 percent resulted from an increase in units sold to wholesalers and the impact of a price increase in 2007.

The gross product margin rate (net product sales less cost of sales as a percent of net pr
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. ViroPharma Shares Fall As FDA Moves Towards Generic Vancocin
2. Autopsy reports could be valuable and informative
3. China reports declining number of SARS Cases
4. Russia Reports First SARS Case
5. Research reports that c-section deliveries are rising
6. Jharkhand reports 13,000 Malaria cases
7. Uganda Reports Failure To Contain Sleeping Sickness
8. WHO reports 36 million deaths world wide due to chronic diseases
9. Reports of Hantavirus infection in India raise concerns
10. Controversy Surrounding The HIV Positive Reports Of One-Year Girl In Kerala
11. China Reports Yet Another Bird Flu Case
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... Colo. (July 8, 2014) A new study from ... modest improvements, poor oral health remains a major problem ... , "The oral health among Native Americans is abysmal ... rest of the country," said Terrence Batliner, DDS, MBA, ... Research at the School of Public Health. "The number ...
(Date:7/10/2014)... July 10, 2014 (HealthDay News) -- Most professional football ... return to the game, a new study finds. ... but their rate of return after surgery to fix ... The new study included 60 players who had ... this procedure successfully returned to play, defined as playing ...
(Date:7/10/2014)... HealthDay Reporter THURSDAY, July ... the hot flashes that often accompany menopause, new research suggests. ... percent of menopausal women, said Dr. Taraneh Shirazian, an assistant ... Icahn School of Medicine at Mount Sinai Hospital in New ... 10 hot flashes a day, and she added that hot ...
(Date:7/10/2014)... By Dennis Thompson ... -- About six out of 10 adults make use of ... to order in restaurants, according to a new U.S. study. ... study,s lead author, Seung Hee Lee-Kwan, an epidemiologist with the ... of women surveyed said they used menu labeling to help ...
(Date:7/10/2014)... on aggression, who research issues ranging from child abuse ... Meeting of the International Society for Research on Aggression ... Georgia State University is hosting the prestigious world meeting, ... , "We are excited to be bringing together leading ... help produce fresh ideas about the causes, consequences and ...
Breaking Medicine News(10 mins):Health News:Study finds widespread oral health problems among Navajo 2Health News:Shoulder Surgery Gets NFL Players Back in the Game 2Health News:Losing Weight May Ease Hot Flashes, Study Finds 2Health News:Losing Weight May Ease Hot Flashes, Study Finds 3Health News:60 Percent of Diners Use Calorie Labeling When Posted: CDC 2Health News:60 Percent of Diners Use Calorie Labeling When Posted: CDC 3Health News:Georgia State hosts national conference on aggression 2Health News:Georgia State hosts national conference on aggression 3
... Knopp Neurosciences Inc. ("Knopp"),announced that Cheryl Fossum Graham, ... president of regulatory and development strategy. (Logo: ... to Knopp 28 years of experience in public ... Food,and Drug Administration and responsibility for global regulatory ...
... ALOKA is announcing today 3 new models of,ProSound Systems ... on,Ultrasound in Obstetrics and Gynecology, 7th to 11th of ... a powerful, friendly and compact,premium ultrasound system, the ProSound ... system worldwide and the ProSound 6,is a new premium ...
... Nancy Pelosi,released the following statement today in recognition ... presented the National Breast,Cancer Coalition,s "Wo(men) Who Get ... "National Breast Cancer Awareness Month is a ... ourselves to advancing prevention, improving,treatments, and funding research ...
... 29, over 850,people in 60 cities across the country ... the Crossfit Fight Gone Bad Challenge to,raise money for ... Cancer,Foundation. Over 4,000 donors supported the cause by contributing ... funds grant from Safeway, the,event raised over $546,000 in ...
... advance in understanding the genetic processes that give flowers, ... lead to a range of benefits, including better understanding ... natural food colourings. The research is highlighted in the ... Sciences Research Council (BBSRC). , The scientists, at the ...
... support services in Los ... Angeles, ... in association with the Will and Jada Smith,Family Foundation hosted the First ... Rey Theatre in Los,Angeles. Actress Jada Pinkett Smith headlined a group of ...
Cached Medicine News:Health News:Cheryl Fossum Graham Joins Knopp Neurosciences as Head of Regulatory and Development Strategy 2Health News:Cheryl Fossum Graham Joins Knopp Neurosciences as Head of Regulatory and Development Strategy 3Health News:Aloka to Unveil New 'ProSound' Diagnostic Ultrasound System at the 17th World Congress on Ultrasound in Obstetrics and Gynecology, 7th to 11th of October 2007 in Florence, Italy 2Health News:Aloka to Unveil New 'ProSound' Diagnostic Ultrasound System at the 17th World Congress on Ultrasound in Obstetrics and Gynecology, 7th to 11th of October 2007 in Florence, Italy 3Health News:Crossfit Workout Challenge Raises Over $500,000 in Four Hours for Athletes for a Cure 2Health News:New research into plant colors sheds light on antioxidants 2Health News:Stars Shine on 'Butterflies Over Hollywood' for Lupus Foundation of America 2
(Date:7/10/2014)... July 10, 2014  RESMED INC. (NYSE: RMD ... and fiscal year ended June 30, 2014 results on Thursday, ... close. A press release with ResMed,s results will be issued ... host a webcast to discuss operating results and future outlook. ... 1:30 p.m. US Pacific Time and the live webcast of ...
(Date:7/10/2014)...  BC Technical, the largest nationwide, non-OEM provider of ... a leading provider of Siemens Nuclear Medicine and Molecular ... BC Technical as the authorized provider of service and ... BC Technical announced today that the two companies have ... the service and systems provider for MiE,s camera systems. ...
(Date:7/10/2014)... , July 10, 2014   Ventana Medical Systems, ... announced it has entered into an agreement with Merck ... as EMD Serono in the United States ... collaborate with Merck KGaA,s biopharmaceutical division on the development ... undisclosed target using Ventana,s proprietary diagnostic assays. In alignment ...
Breaking Medicine Technology:ResMed To Announce Fourth Quarter And Fiscal Year-End 2014 Results 2BC Technical Partners With MiE America To Be Authorized Provider Of Systems & Service 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 3
... Oct. 17, 2011 Archimedes Pharma Ltd., and its ... (fentanyl) nasal spray is now available by prescription in ... breakthrough pain in cancer patients 18 years of age ... tolerant to opioid therapy for their underlying persistent cancer ...
... Calif., Oct. 17, 2011 Abaxis, Inc. (NasdaqGS: ABAX), a ... a conference call to discuss its financial results for the ... The call will be at 4:15 p.m. ET on Tuesday, ... the second quarter of fiscal year 2012 after the market ...
Cached Medicine Technology:Archimedes Pharma Launches Lazanda® - the Only Fentanyl Nasal Spray for the Management of Breakthrough Pain in Cancer in the U.S. 2Archimedes Pharma Launches Lazanda® - the Only Fentanyl Nasal Spray for the Management of Breakthrough Pain in Cancer in the U.S. 3Archimedes Pharma Launches Lazanda® - the Only Fentanyl Nasal Spray for the Management of Breakthrough Pain in Cancer in the U.S. 4Archimedes Pharma Launches Lazanda® - the Only Fentanyl Nasal Spray for the Management of Breakthrough Pain in Cancer in the U.S. 5Archimedes Pharma Launches Lazanda® - the Only Fentanyl Nasal Spray for the Management of Breakthrough Pain in Cancer in the U.S. 6Archimedes Pharma Launches Lazanda® - the Only Fentanyl Nasal Spray for the Management of Breakthrough Pain in Cancer in the U.S. 7Abaxis to Report Second Quarter Fiscal Year 2012 Financial Results Tuesday, October 25, 2011 2
The Trident PSL Acetabular Shells are designed to maximize fixation in the peripheral lunate region of the acetabulum....
... has been designed to enhance fixation in ... hole configurations. The objective of the product ... primary modes: Tilt, migration and rotation. The ... initial and long-term fixation. The porous coating ...
The Biopro All Poly cup is a uniquely designed UHMWPE acetabular cup....
The MPF cup is specifically designed to achieve high primary stability, a critical factor for long term success....
Medicine Products: